Skip to content
Home/Companies/Healthcare/Oxford Drug Design
OD

Oxford Drug Design

Healthcare·UK·Active

Oxford Drug Design is a healthcare company, headquartered in UK.

Entry
–
Hold
–
Status
Active
Est. EV
–

Who owns Oxford Drug Design?

Oxford Drug Design is currently owned by ACF Investors through Angel CoFund (2011 vintage).

Hand-verified · updated 2026-04-21

ACF Investors
Investor
ACF Investors
Angel CoFund · 2011 · VC

Key facts

HQUK
SectorHealthcare

More from Angel CoFund

Other portfolio companies in the same fund.

1415032213 Imspex Gas
Active
EnergyUK
1416929592 Creo
Active
SoftwareUK
1553099493 Cropped2
Active
UK
Adventoris
Active
TMTUK
Angel Syndicates
Active
TMTUK
Arrow Risk Management
Active
FinancialsUK

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
4ways
Active
ECI PartnersUK
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abcam (exited)
Active
EMV CapitalUK
Data refreshed weekly · Sourced from public filings